ANI Pharmaceuticals ANIP Enterprise value

Enterprise value at other companies

Amneal Pharmaceuticals, Inc.AMRX

$7.97B+71.3%

ViatrisVTRS

$31.23B+26.4%

AnaptysBio, Inc.ANAB

$1.35B+176%

ALN

Alnylam PharmaceuticalsALNY

$38.74B-6.7%

Eton Pharmaceuticals, Inc.ETON

$684.98M+89.8%

Aurinia PharmaceuticalsAUPH

$2.08B+83.9%

FAQ

What is ANI Pharmaceuticals's enterprise value?

ANI Pharmaceuticals (ANIP) reported enterprise value of $1.82B in Q2 2026.

How has ANI Pharmaceuticals's enterprise value changed year-over-year?

ANI Pharmaceuticals's enterprise value increased by 17.9% year-over-year, from $1.55B to $1.82B.

What is the long-term trend for ANI Pharmaceuticals's enterprise value?

Over 5 years (2020 to 2025), ANI Pharmaceuticals's enterprise value has grown at a 22.2% compound annual growth rate (CAGR), from $662.21M to $1.81B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.